Acellular Amniotic Fluid for Ischemic Injury Treatment
Summary
USPTO granted patent US12599635B2 to University of Utah Research Foundation covering compositions and methods for treating ischemic injuries using acellular amniotic fluid (acAF). The patent names inventors Hadi Javan, Craig H. Selzman, Young Sook Lee, Jo-Anna Reems, and Jan L. Pierce, and includes 31 claims. The patent application was filed March 22, 2021 under application number 17912730.
What changed
USPTO granted patent US12599635B2 to University of Utah Research Foundation for compositions and methods of treating ischemic injuries using acellular amniotic fluid. The patent covers administering therapeutically effective amounts of acAF to ischemic injury sites within therapeutic time windows. Healthcare providers and researchers should monitor this intellectual property development as it may affect future research directions and potential licensing opportunities for ischemic injury treatments.
For pharmaceutical companies and medical researchers, this patent establishes exclusive rights for the use of acellular amniotic fluid in ischemic injury treatment, potentially limiting independent development of similar therapies without licensing arrangements with the assignee.
What to do next
- Monitor for updates
Archived snapshot
Apr 15, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Compositions and treatments for ischemic injuries
Grant US12599635B2 Kind: B2 Apr 14, 2026
Assignee
University of Utah Research Foundation
Inventors
Hadi Javan, Craig H. Selzman, Young Sook Lee, Jo-Anna Reems, Jan L. Pierce
Abstract
Described herein are compositions and methods for treating ischemic injury in a subject comprising administering a therapeutically effective amount of an acellular amniotic fluid (acAF) to an ischemic injury situs within a therapeutic time window.
CPC Classifications
A61K 35/50 A61K 38/014 A61K 31/728 A61K 2300/00 A61P 9/10
Filing Date
2021-03-22
Application No.
17912730
Claims
31
Related changes
Get daily alerts for USPTO Patent Grants - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.